Gene · 9075
Papers2,543
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,543
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. | J Gastroenterol | 2023 | 37160449 | PubTator, text mining | PubMed |
| Predictive Significance of Claudin-3 for Epithelial Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps. | Allergy Asthma Immunol Res | 2023 | 37153980 | PubTator, text mining | PubMed |
| Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV. | Front Immunol | 2023 | 37153621 | PubTator, text mining | PubMed |
| Claudin-2 in hyperproliferative migrating keratinocytes and migration inhibition via siRNA knockdown. | Anat Histol Embryol | 2023 | 37147871 | PubTator, text mining | PubMed |
| Bile acid diarrhea - as bad as it gets? | Curr Opin Gastroenterol | 2023 | 37144536 | PubTator, text mining | PubMed |
| Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function. | Food Funct | 2023 | 37128780 | PubTator, text mining | PubMed |
| The shaping of gut immunity in cirrhosis. | Front Immunol | 2023 | 37122743 | PubTator, text mining | PubMed |
| Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. | World J Gastroenterol | 2023 | 37122604 | PubTator, text mining | PubMed |
| Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-κB pathway. | Chem Biol Interact | 2023 | 37121296 | PubTator, text mining | PubMed |
2'-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome. | Nutrients | 2023 | 37111064 | PubTator, text mining | PubMed |
| Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer. | Molecules | 2023 | 37110709 | PubTator, text mining | PubMed |
| From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders. | Microorganisms | 2023 | 37110329 | PubTator, text mining | PubMed |
| Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing. | Int J Mol Sci | 2023 | 37108564 | PubTator, text mining | PubMed |
| Emerging role of bacterial outer membrane vesicle in gastrointestinal tract. | Gut Pathog | 2023 | 37106359 | PubTator, text mining | PubMed |
| Kidney stones, hypercalciuria, and recent insights into proximal tubule calcium reabsorption. | Curr Opin Nephrol Hypertens | 2023 | 37074688 | PubTator, text mining | PubMed |
| Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier. | BMC Biol | 2023 | 37072819 | PubTator, text mining | PubMed |
| Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance. | Front Pharmacol | 2023 | 37063290 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| The effects of fresh mango consumption on gut health and microbiome - Randomized controlled trial. | Food Sci Nutr | 2023 | 37051355 | PubTator, text mining | PubMed |
| Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management. | Food Sci Nutr | 2023 | 37051344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9075/papers?page=18